Conversely, CD8+ T cells are responsible for anti-tumor responses, and increased CD8+ T cell infiltration usually indicates a better prognosis in LIHC (Yan et al., 2018; Ansari et al., 2020; Li et al., 2020). Here, CD8A is linked to neoplasm.